← All candidates
16 insider filings on record.
19 filings on record.
PROKPROKIDNEY CORP.
NasdaqCM · Healthcare · $694.58M
$1.74
-3.87% · Sep 15
16 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 10 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$694.58M
Float
160.5M
77% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
849.1
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
11 more transactions on Pro →Context
Wall St
$6.25 avg target
+259.2% vs today · 6 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.15 act−$0.01
Q1 '26−$0.14 act−$0.00
Q4 '25−$0.14 act+$0.01
Q3 '25−$0.12 act+$0.02
Coverage
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue EstimatesZacks · 08-10Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval PathInsider Monkey · 06-17ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue EstimatesZacks · 05-15ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for RilparencelInsider Monkey · 05-01
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice